Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients: Meta-analysis of Efficacy in Pivotal Randomized Controlled Trials

被引：0
|
作者：
Manier, Salomon [1 ]
Robinson, Suzanne [2 ]
Owen, Melody [3 ]
Dhanasiri, Sujith [2 ]
Frederickson, Andrew [3 ]
Jackson, Graham [4 ]
Facon, Thierry [1 ]
机构：
[1] CHU Lille, Dept Haematol, Lille, France
[2] Celgene Corp, Summit, NJ USA
[3] Precis Xtract, Oakland, CA USA
[4] NCCC Freeman Hosp, Clin Haematol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
meta-analysis; Multiple myeloma;
D O I：
10.1016/j.clml.2019.09.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-012
引用
收藏
页码：E9 / E10
页数：2
相关论文
共 50 条
  • [31] Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma
    Forsberg, Peter A.
    Rossi, Adriana C.
    Boyer, Angelique
    Pearse, Roger N.
    Pekle, Karen A.
    Jayabalan, David
    Lakritz, Stephanie
    Flicker, Kari
    Ribadeneyra, Drew
    Liotta, Brielle
    Ely, Scott
    Boussi, Leora
    Allan, John N.
    Coleman, Morton
    Niesvizky, Ruben
    Mark, Tomer M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1554 - 1562
  • [32] Heart Failure with Carfilzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials
    Rahman, M. Rubayat
    Ball, Somedeb
    Paz, Pablo
    Elmassry, Mohamed
    Vutthikraivit, Wasawat
    Bandyopadhyay, Dhrubajyoti
    Lavie, Carl J.
    Fonarow, Gregg C.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 610 - 612
  • [33] Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
    Liang, Dong
    Bai, Shenrui
    Feng, Demei
    Chen, Guanjun
    Liang, Yang
    Wang, Hua
    BMC CANCER, 2024, 24 (01)
  • [34] Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
    Slade, Michael
    Martin, Thomas G.
    Nathwani, Nitya
    Fiala, Mark A.
    Rettig, Michael P.
    Gao, Feng
    Deol, Abhinav
    Buadi, Francis K.
    Kaufman, Jonathan L.
    Hofmeister, Craig C.
    Gregory, Tara K.
    Berdeja, Jesus
    Chari, Ajai
    Rosko, Ashley
    Vij, Ravi
    LEUKEMIA, 2022, 36 (12) : 2917 - 2921
  • [35] Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma
    Michael Slade
    Thomas G. Martin
    Nitya Nathwani
    Mark A. Fiala
    Michael P. Rettig
    Feng Gao
    Abhinav Deol
    Francis K. Buadi
    Jonathan L. Kaufman
    Craig C. Hofmeister
    Tara K. Gregory
    Jesus Berdeja
    Ajai Chari
    Ashley Rosko
    Ravi Vij
    Leukemia, 2022, 36 : 2917 - 2921
  • [36] Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib plus Lenalidomide plus Dexamethasone or Bortezomib plus Thalidomide plus Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma
    Rosinol Dachs, Laura
    Hebraud, Benjamin
    Oriol, Albert
    Colin, Anne-Laurene
    Rios, Rafael
    Hulin, Cyrille
    Jesus Blanchard, Maria
    Caillot, Denis
    Sureda, Anna
    Hernandez, Miguel T.
    Arnulf, Bertrand
    Mateos, Maria-Victoria
    Macro, Margaret
    San-Miguel, Jesus F.
    Belhadj, Karim
    Jose Lahuerta, Juan
    Chen, Guang
    Garelik, M. Brigid
    Blade, Joan
    Moreau, Philippe
    Attal, Michel
    BLOOD, 2018, 132
  • [37] A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
    Khan, Meaghan L.
    Reeder, Craig B.
    Kumar, Shaji K.
    Lacy, Marthy Q.
    Reece, Donna E.
    Dispenzieri, Angela
    Gertz, Morie A.
    Greipp, Phillip
    Hayman, Suzanne
    Zeldenhurst, Steven
    Dingli, David
    Lust, John
    Russell, Stephen
    Laumann, Kristina M.
    Mikhael, Joseph R.
    Bergsagel, P. Leif
    Fonseca, Rafael
    Rajkumar, S. Vincent
    Stewart, A. Keith
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 326 - 333
  • [38] Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide
    Kobayashi, Takahiro
    Miura, Masatomo
    Niioka, Takenori
    Fujioka, Yuki
    Abumiya, Maiko
    Yoshioka, Tomoko
    Kameoka, Yoshihiro
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    BLOOD, 2017, 130
  • [39] Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes
    Shah, Jatin J.
    Abonour, Rafat
    Gasparetto, Christina
    Hardin, James W.
    Toomey, Kathleen
    Narang, Mohit
    Srinivasan, Shankar
    Kitali, Amani
    Zafar, Faiza
    Flick, E. Dawn
    Rifkin, Robert M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (09): : 575 - +
  • [40] SAFETY AND EFFICACY OF LENALIDOMIDE PLUS DEXAMETHASONE IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS 70 YEARS OF AGE AND OLDER
    Gay, F.
    Hayman, S.
    Buadi, F.
    Detweiler-Short, K.
    Lacy, M.
    Kumar, S.
    Dispenzieri, A.
    Gertz, M.
    Rajkumar, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 153 - 153
12345